Skip to content

EyePoint, Inc. EYPT Change in Other Assets

Change in Other Assets at other companies

Ocular Therapeutix logo
Ocular TherapeutixOCUL
$357K+109%
Kodiak Sciences Inc logo
Kodiak Sciences IncKOD
$975K+3,582%
HRO
HarrowHROW
-$346K-15.7%
Theravance Biopharma logo
Theravance BiopharmaTBPH
-$1.03M-211%
LQD
Liquidia CorporationLQDA
$4.6M-0.5%
MeiraGTx Holdings plc logo
MeiraGTx Holdings plcMGTX
-$1.28M

Other financials

Income statement

See full
Revenue$696.0K-97.2%
Gross profit$9.8M-30.1%
Operating income-$87.2M-78.6%
Net income-$84.8M-87.7%
EPS (diluted)-$0.99-52.3%

Balance sheet

See full
Cash & equivalents$77.7M-8.7%
Total debt$22.3M-7.3%
Total equity$230.5M-22.8%
Total assets$288.2M-20.5%

Cash flow

See full
Operating cash flow-$80.5M-51.6%
CapEx$997.0K+261%
Free cash flow-$81.5M-52.7%

Valuation

See full
Market cap$1.21B+189%
Enterprise value$1.15B+228%
P/S158.5×+151×

Profitability

See full
Operating margin-3,700.9%-4,042pp
Net margin-3,566.6%-3,874pp
FCF margin-3,565.9%-3,884pp

Returns & leverage

See full
Return on equity-102.7%+1,157pp
Debt / equity0.1×0.0×
Current ratio6.7×-1.2×

Where this comes from

Reported directly by EyePoint, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherNoncurrentAssets.

The official record: EyePoint, Inc. ’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about EyePoint, Inc. 's change in other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is EyePoint, Inc. 's change in other assets?
EyePoint, Inc. (EYPT) reported change in other assets of $3.36M in Q1 2026.
How has EyePoint, Inc. 's change in other assets changed year-over-year?
EyePoint, Inc. 's change in other assets increased by 7534.1% year-over-year, from $44K to $3.36M.
What does change in other assets mean?
Change in miscellaneous assets affecting operating cash flow.